Test Price
1,200 AEDโ Home Collection Available
N-MYC Oncogene Test (FISH) in UAE | 1,200 AED | DNA Labs UAE
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified processing for MYCN gene amplification detection in neuroblastoma tumour tissue.
Specimen Logistics: Secure Medical Courier Solid Tissue Specimen Retrieval โ temperature-controlled chain-of-custody transport for fresh, frozen, or FFPE tumour blocks. Mobile home phlebotomy is not applicable for this archival tissue test.
Clinical Guidance: Telephonic post-test interpretation by a board-certified specialist; results require holistic correlation with histology and imaging.
Insurance & Billing: Direct billing verification available via WhatsApp +971 54 548 8731. Self-pay and third-party claims accepted.
Price: 1,200 AED (inclusive of GST, courier, and certified report).
Test Overview & Methodology
The N-MYC Oncogene Test employs Fluorescence In-Situ Hybridization (FISH) to detect amplification of the MYCN gene in tumour tissue. This assay is a cornerstone prognostic and risk-stratification marker for neuroblastoma and other neural crest tumours. FISH directly visualises gene copy number within intact tumour cell nuclei, providing a gold-standard binary readout of amplification status that guides risk-adapted therapy protocols.
| Parameter | DNA Labs UAE N-MYC FISH Test | Common Alternative (NGS Panel) |
|---|---|---|
| Precision | Gold-standard direct visualisation of amplification status at single-cell resolution | Indirect copy-number inference; may miss low-level or heterogeneous amplifications |
| Methodology | Fluorescence In-Situ Hybridization (FISH) | Next-Generation Sequencing (NGS) |
| Turnaround Time | 7โ8 working days | 14โ21 working days |
| Cost | 1,200 AED | 3,500โ5,000 AED |
| Regulatory Compliance | DHA/MOHAP compliant, ISO 9001:2015 certified | Variable across laboratories |
Important Pre-Test Information
A valid doctorโs prescription is mandatory. This test is not indicated for surgical clearance, pregnancy screening, or travel requirements; it requires clinical suspicion of neuroblastoma. Patients on anticoagulant therapy must inform the referring clinician prior to biopsy. Secure cold-chain courier transport is strictly maintained for all tumour specimens.
Physician Insight & Safety Protocols
Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA Registration ID: 61713011
โA positive N-MYC amplification result by FISH is a powerful adverse prognostic indicator in neuroblastoma and must be interpreted alongside cross-sectional imaging, histologic subtype classification, and patient age at diagnosis. It guides risk-adapted therapeutic stratification but is not a standalone diagnostic verdict. All findings require holistic multi-disciplinary correlation for tailored management planning.โ
Therapy Advisory Notice
Do not alter or discontinue any prescribed chemotherapy, immunotherapy, or targeted agent without direct consultation with your treating oncologist. Laboratory results may be modulated by concurrent therapeutic regimens; always coordinate specimen collection timing with your clinical team to ensure accurate interpretation.
Exclusion Criteria & Emergency Red Flags
- Insufficient or non-viable tumour tissue โ biopsy repeat may be required to obtain adequate cellular material.
- Uncorrected bleeding disorders or active anticoagulation without documented medical clearance from the referring physician.
- Emergency red flags requiring immediate activation of 998: sudden severe pain at the tumour site, uncontrollable haemorrhage, acute neurological deterioration, or signs of adrenal crisis (hypotension, high fever, confusion, syncope).
Patient FAQ & Clinical Guidance
1. What is the N-MYC FISH test and why is it ordered?
This test uses Fluorescence In-Situ Hybridization to directly visualise MYCN gene copies in tumour cell nuclei, determining amplification status. It is ordered specifically for neuroblastoma risk stratification and prognosis. The result directly influences whether a child receives standard or intensified chemotherapy protocols.
2. Do I need a prescription and how is the specimen collected?
Yes, a valid doctorโs prescription is mandatory because this test is clinically indicated only for suspected neural crest tumours. The specimen is an archival tissue block or fresh tumour biopsy โ a secure medical courier retrieves the solid tissue directly from the hospital pathology department. Home phlebotomy is not available for this test.
3. How long does it take and how will I receive the results?
Results are delivered within 7โ8 working days from specimen receipt at our Dubai Healthcare City laboratory. The final report is shared via encrypted email or secure patient portal and includes the amplification status, signal ratio, and an interpretive comment from the reporting pathologist.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with all applicable UAE federal data protection and health information security frameworks. Patient data is processed and stored in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory processes are ISO 9001:2015 certified and subject to regular DHA audit.
No test result is released without verified physician requisition and written patient consent. Specimens and associated data are retained only for the clinically necessary duration and destroyed per approved retention schedules.
Clinical & Logistical Metadata
| Test Name | N-MYC Oncogene Test (FISH) |
| Price (AED) | 1,200 AED |
| Turnaround Time | 7โ8 Working Days |
| Sample Type / Matrix | Tumor Tissue (Fresh, Frozen, or Formalin-Fixed Paraffin-Embedded Blocks) โ Archival Specimen |
| Methodology Used | Fluorescence In-Situ Hybridization (FISH) |
| ICD-10-CM Code | C74.90 (Malignant neoplasm of unspecified part of unspecified adrenal gland โ neuroblastoma) |
| LOINC Code | 33766-4 (MYCN gene amplification [Presence] in Tissue by FISH) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians